Alimenté par : Claudia (ADFI Alsace)
Cet outil s'appuie sur PubMind
PubMind est une plateforme collaborative de veille scientifique qui permet d'importer des publications depuis PubMed, de suivre leur avancement de lecture, d'en extraire les éléments méthodologiques clés (protocoles, variables, résultats) et de constituer une synthèse structurée afin de faciliter la réalisation de revues de littérature. Entièrement personnalisable, cet outil s'adapte aux thématiques de recherche de ses utilisateurs.
Nous l'avons configuré ici pour centraliser et analyser la littérature scientifique concernant les croyances, les traitements psychologiques, l'étude de la scrupulosité, ainsi que l'impact et la prise en charge des troubles liés aux dérives sectaires.
Dernière synchronisation le 05/06/2026
Psychedelic Med (New Rochelle) . 2025;3 (4) :172-191
BACKGROUND: Although historical writings, anthropological accounts, and experimental studies document associations between psilocybin use and religion, no prospective experimental study has investigated how the effects of psilocybin are experienced and interpreted by religious clergy. This exploratory study evaluated the overall safety and the acute and enduring effects of psilocybin in clergy.METHODS: Participants were psychedelic-naïve clergy from various major world religions. A randomized, parallel group, waitlist control design was used to assess the effects of two supported psilocybin sessions, with participants receiving 20 and then 20 or 30 mg/70 kg about 1 month later. Outcomes were compared between the Immediate Group ( = 13) and the Delayed Group ( = 16) at 6 months after screening using self-report measures. The effects of psilocybin were also assessed on session days and 4 and 16 months after the second psilocybin session in the 24 participants who completed both sessions.RESULTS: The primary outcome assessment at 6 months after screening showed that, compared with the delayed control group, participants who had received psilocybin reported significantly greater positive changes in their religious practices, attitudes about their religion, and effectiveness as a religious leader, as well as in their non-religious attitudes, moods, and behavior. Follow-up assessments showed that positive changes in religious and non-religious attitudes and behavior were sustained through 16 months after the second psilocybin session. At that time, participants rated at least one of their psilocybin experiences to be among the top five most spiritually significant (96%), profoundly sacred (92%), psychologically insightful (83%), and psychologically meaningful (79%) of their lives. Furthermore, 42% rated one of their experiences to be the single most profound of their lifetime. At 16-months follow-up, most (79%) strongly endorsed that the experiences had positive effects on their religious practices (e.g., prayer or meditation) and their daily sense of the sacred, and most (71%) reported positive changes in their appreciation of religious traditions other than their own. Although no serious adverse events were reported, 46% rated a psilocybin experience as among the top five most psychologically challenging of their lives.CONCLUSIONS: In this population of clergy, psilocybin administration was safe and increased multiple domains of overall psychological well-being including positive changes in religious attitudes and behavior as well as their vocation as a religious leader. The study was limited by a waitlist control design, homogenous sample, and the use of some unvalidated outcome measures. Further research with more rigorous control conditions and diverse samples is needed.